2024-03-29T09:32:01Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_1127C971AF42
2024-03-23T01:51:40Z
serval:BIB_1127C971AF42
Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial.
10.1136/annrheumdis-2011-200373
21998121
000301066500017
Genevay
S.
author
Finckh
A.
author
Zufferey
P.
author
Viatte
S.
author
Balagué
F.
author
Gabay
C.
author
article
2012
Annals of the Rheumatic Diseases
1468-2060
0003-4967
journal
71
4
560-562
Acute Disease
Adult
Anti-Inflammatory Agents/administration & dosage
Anti-Inflammatory Agents/therapeutic use
Antibodies, Monoclonal, Humanized/administration & dosage
Antibodies, Monoclonal, Humanized/therapeutic use
Back Pain/etiology
Diskectomy
Double-Blind Method
Female
Follow-Up Studies
Humans
Injections, Subcutaneous
Kaplan-Meier Estimate
Magnetic Resonance Imaging
Male
Middle Aged
Sciatica/complications
Sciatica/drug therapy
Treatment Outcome
Tumor Necrosis Factor-alpha/antagonists & inhibitors
eng
60_published
Publication types: Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
Publication Status: ppublish